Characterization of cytotoxic activity of saporin anti‐gp185/HER‐2 immunotoxins
- 19 August 1993
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 55 (1) , 122-127
- https://doi.org/10.1002/ijc.2910550122
Abstract
The oncogene HER-2/neu encodes a trans-membrane receptor of 185 kDa with tyrosine-kinase activity. Over-expression of this molecule has been reported in a significant proportion of human breast and ovarian carcinomas, characterized by a poor clinical prognosis. Two monoclonal antibodies (MAbs), recognizing distinct epitopes of the gp 185 extracellular domain, have been utilized in the present study for the production of immunotoxins (ITs) by conjugation to the type-1 RIP (ribosome-inactivating protein) plant toxin saporin 6 (SAP). These ITs have been shown to retain tumor-specificity and specifically to inhibit protein synthesis in the gp 185HER-2(+) SK-BR-3 breast-carcinoma cell line with IC50 values lower then I nM. Kinetics of the cytotoxic activity of the ITs are characterized by a slow rate, since incubation times ranging from 24 to 60 hr, depending on the different degree of expression of the receptor, are required to determine > 90% inhibition in the incorporation of radiolabeled leucine. However, the cytotoxic activity of these ITs, as evaluated by a more sensitive clonogenic assay, appears highly potent, since we have observed that 3 to 4 logs of cells are killed upon exposure to the ITs for short times at concentrations ranging from 1 to 5 × 10−8 M.Keywords
This publication has 16 references indexed in Scilit:
- Production and Characterization of Murine mAbs to the Extracellular Domain of Human Neu Oncogene Product GP185HER2Hybridoma, 1992
- Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxinThe Lancet, 1992
- Isolation of the NeuHER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cellsCell, 1992
- Expression of the p185 encoded by her2 oncogene in normal and transformed human tissuesInternational Journal of Cancer, 1990
- Theneu-oncogene protein as a predictive factor for haematogenous metastases in breast cancer patientsInternational Journal of Cancer, 1990
- Immunotoxins containing saporin 6 and monoclonal antibodies recognizing plasma cell‐associated antigens: Effects on target cells and on normal myeloid precursors (CFU‐GM)European Journal of Haematology, 1989
- Activity of a Monoclonal Antibody-Saporin-6 Conjugate Against B-Lymphoma CellsJNCI Journal of the National Cancer Institute, 1988
- Response of primary human mammary tumor cell cultures to a monoclonal antibody-recombinant ricin A chain immunotoxinCancer Immunology, Immunotherapy, 1988
- erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 CellsScience, 1987
- Characterization of a Saponaria officinalis seed ribosome-inactivating protein: Immunoreactivity and sequence homologiesBiochemical and Biophysical Research Communications, 1985